Does Medicaid Cover Inhalers? Pharmacy Costs and Coverage Rules

Medicaid does cover inhalers in all 50 states, the District of Columbia, and Puerto Rico. Prescription drug coverage is technically optional under federal law, but every state has chosen to offer it, and inhalers for asthma and COPD fall squarely within that benefit.1KFF. 5 Key Facts About Medicaid Prescription Drugs What varies, sometimes dramatically, is which specific inhaler your plan prefers, what you pay at the counter, and how much paperwork your doctor has to do before the pharmacy will dispense it.

What You’ll Pay at the Pharmacy

Medicaid copays for inhalers are low. New York, as one example, charges $1.00 for a preferred brand or generic drug and $3.00 for a non-preferred brand, with a $50-per-quarter cap on total Medicaid copays across all services. Anyone who cannot afford a copay still gets the medication.2eMedNY. Pharmacy Benefits About 71% of Medicaid programs apply some copay to asthma medications.3CDC. Medicaid Coverage of Guidelines-Based Asthma Care Across 50 States, the District of Columbia, and Puerto Rico

One thing to know: the $35-per-month inhaler price caps that AstraZeneca, Boehringer Ingelheim, and GSK rolled out in 2024 and 2025 are not available to Medicaid enrollees. Those manufacturer programs are for commercially insured and uninsured patients, and Medicaid, Medicare, CHIP, and TRICARE members are explicitly excluded.4AAFA Community. What You Need to Know About the $35 Price Cap on Asthma Inhalers5Peterson-KFF Health System Tracker. How Recent Manufacturer Savings Programs May Impact Individual Out-of-Pocket Spending on Asthma and COPD Inhalers Medicaid copays are already well below $35, so most beneficiaries aren’t missing out on savings. They just aren’t eligible for the programs.

Why One Inhaler Is Easy To Fill and Another Isn’t

Every state Medicaid program maintains a preferred drug list. For inhalers, that means certain products can be dispensed with just a prescription, while others, labeled “non-preferred,” require prior authorization before the pharmacy will release them.6PMC. Oral Albuterol on State Medicaid Preferred Drug Lists The classifications can look arbitrary from the counter. New York, for instance, lists generic albuterol HFA, Proventil HFA, and Ventolin HFA as preferred rescue inhalers, but the generic version of Ventolin HFA is non-preferred and needs prior authorization.7eMedNY. NYRx Drug Coverage List The categories reflect rebate negotiations between the state and the manufacturer, not clinical judgments about the drug.

Prior authorization is only one of three tools states use. The others are step therapy, which requires you to try and fail cheaper options first, and quantity limits, which cap how many inhalers you can get in a given period. A 2021–2022 CDC survey of Medicaid programs found these barriers everywhere. For quick-relief inhalers like albuterol, about 83% of programs required prior authorization for at least some products, 79% imposed quantity limits, and 73% used step therapy. For controller medications such as inhaled corticosteroids, the figures climbed to 98%, 87%, and 89%.3CDC. Medicaid Coverage of Guidelines-Based Asthma Care Across 50 States, the District of Columbia, and Puerto Rico

Step therapy is especially common for maintenance inhalers used in COPD. In Illinois, a patient seeking Breo Ellipta must first try and fail both a fluticasone/salmeterol product and a budesonide/formoterol product. Trelegy Ellipta requires documented failure of both a long-acting beta agonist and a long-acting muscarinic antagonist used together.8Meridian Health Plan of Illinois. Inhaled Asthma and COPD Agents Clinical Policy Arkansas Medicaid classifies both Trelegy and Breo as non-preferred and steers patients toward Advair Diskus, Symbicort, and Spiriva Handihaler instead, each with its own quantity limits and diagnostic requirements.9Arkansas Department of Human Services. Arkansas Medicaid Pharmacy Memo

Quantity limits can be a real problem for families whose kids need an inhaler at home and another at school or daycare. The CDC noted these restrictions can be particularly detrimental to children who need multiple inhalers across settings.3CDC. Medicaid Coverage of Guidelines-Based Asthma Care Across 50 States, the District of Columbia, and Puerto Rico Some plans grant exceptions for children in foster care, in daycare, or with multiple caregivers.8Meridian Health Plan of Illinois. Inhaled Asthma and COPD Agents Clinical Policy If quantity limits are a problem for your household, ask the prescriber to request an exception.

Nebulizers and Spacers

Medicaid also covers nebulizers, which turn liquid medication into a mist and are useful for young children or anyone who can’t coordinate a metered-dose inhaler. In most states (88% as of 2019), nebulizers are classified as durable medical equipment rather than pharmacy items, so you may get the device from a DME supplier and the liquid medication from the pharmacy separately. About a third of states require prior authorization for nebulizers, and 59% impose quantity limits.10American Lung Association. Medicaid DME Primer

Spacers and valved-holding chambers, which attach to a metered-dose inhaler to improve delivery, are covered too. About 69% of states treat them as DME; the rest handle them through the pharmacy benefit.10American Lung Association. Medicaid DME Primer For children under 21, federal guidance says Medicaid cannot impose arbitrary caps like “one spacer per lifetime,” because that would conflict with Early and Periodic Screening, Diagnostic and Treatment protections.11CMS. State Medicaid Director Letter on Asthma

If the Pharmacy Says Your Inhaler Isn’t Covered

When a pharmacist tells you Medicaid won’t cover a prescribed inhaler, that usually means it needs prior authorization, not that it’s off the table entirely. The prescribing doctor submits clinical documentation explaining why that particular inhaler is medically necessary. Federal law requires Medicaid programs to respond to prior authorization requests for outpatient drugs within 24 hours, and to dispense a 72-hour emergency supply while the request is pending.12KFF. Prior Authorization for Medicaid Prescription Drugs

If the request is denied, you can appeal. The plan or state must send a written notice explaining why. You or your provider can then challenge the decision through the plan’s internal appeal process; starting January 1, 2026, plans must give the requesting provider specific reasons for a denial.13MACPAC. Prior Authorization in Medicaid If that doesn’t work, you can request a fair hearing before an administrative law judge.12KFF. Prior Authorization for Medicaid Prescription Drugs

A few practical moves can speed things along. Ask your managed care plan for the medical necessity criteria it uses, so your doctor knows exactly what to document. Ask whether a peer-to-peer review is available, where your prescribing doctor talks directly with a physician at the plan.13MACPAC. Prior Authorization in Medicaid States generally don’t do much to tell beneficiaries about these rights, so being proactive with your pharmacist and doctor matters.12KFF. Prior Authorization for Medicaid Prescription Drugs

If You Were Switched Off Flovent

A lot of Medicaid patients lost access to their usual inhaler in early 2024, and the reason is worth knowing. In January 2024, GSK discontinued brand-name Flovent HFA, one of the most prescribed inhaled corticosteroids, and replaced it with an authorized generic distributed through Prasco Laboratories. GSK acknowledged the move was driven by changes to the Medicaid rebate structure under the American Rescue Plan Act. By launching an authorized generic with no price history, the company avoided an estimated $367.6 million in Medicaid rebates for 2024.14U.S. Senate. Flovent Investigation Report

Even though the authorized generic’s list price was about 35% lower, the net cost to plans ran much higher because the rebates that had made brand Flovent affordable were gone. Many plans moved patients to alternatives like Pulmicort.15Forbes. New Medicaid Rebate Rule Causes Problems for Asthma Patients on Flovent An October 2024 study found a 17.5% increase in asthma-related hospitalizations in the three months after the discontinuation, and the share of chronic inhaler users who stopped treatment altogether more than doubled, from 8.6% to 19%. In March 2026, the FDA approved the first true generic version of Flovent HFA, made by Glenmark Specialty SA, which should ease access over time.14U.S. Senate. Flovent Investigation Report If you were moved off Flovent and your current inhaler isn’t working, ask your doctor about the Glenmark generic or request a prior authorization for the alternative that worked for you before.

If You Have Both Medicare and Medicaid

If you’re enrolled in both programs, your inhaler comes through Medicare Part D, not Medicaid’s pharmacy benefit. That has been the rule since January 2006. Dual-eligible beneficiaries automatically qualify for the Low-Income Subsidy, which eliminates Part D premiums and deductibles and holds copays between $1.00 and $5.00 per prescription. If Part D excludes a particular drug, your state Medicaid program may still cover it, as long as the state covers that drug for its other Medicaid enrollees.16Louisiana Medicaid. Provider Update: Medicare Part D and Dual Eligibles